Literature DB >> 30205888

Relation of Obstructive Sleep Apnea to Risk of Hospitalization in Patients With Heart Failure and Preserved Ejection Fraction from the National Inpatient Sample.

Abdullah Abdullah1, George Eigbire2, Amr Salama2, Abdul Wahab2, Ninad Nadkarni2, Richard Alweis3.   

Abstract

Obstructive Sleep Apnea (OSA) increases the risk of diastolic dysfunction and heart failure. The impact of OSA on hospitalization for heart failure with preserved ejection fraction (HFpEF) is not well elucidated. We used data from the National Inpatient Sample for the years 2012 to 2014. We identified discharges (age ≥18 years) associated with OSA and HFpEF using the International Classification of Diseases, Ninth Revision, Clinical Modification codes (327.23 and 428.3x), respectively. Propensity score analysis, adjusting for age, gender, race, and comorbidities, compared the rates of admission for HFpEF in patients with OSA to those without OSA. Out of 12,608,637 discharges included, there were 147,463 patients with HFpEF, and 653,762 or 5.2% of all discharges had OSA. The prevalence of OSA in patients with HFpEF was 16.8%. Patients with OSA were older, more likely to be men, more likely to have diabetes, hypertension, history of coronary artery disease, chronic kidney disease, obesity, atrial fibrillation, African-American race, and smoking status. In patients with OSA, HFpEF occurred in 3.8% versus 1.0%, with adjusted odds ratio: 2.2 (95% confidence interval 2.16 to 2.23), p <0.001. Subgroup analysis showed similar results in men and women. After propensity score matching, OSA was associated with increased risk of admission with HFpEF, relative risk = 2.2 (95% confidence interval 2.12 to 2.21). In conclusion, OSA was associated with increased risk of hospitalization for HFpEF.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30205888     DOI: 10.1016/j.amjcard.2018.04.052

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

1.  Association Between Sleep Disordered Breathing and Left Ventricular Function: A Cross-Sectional Analysis of the ECHO-SOL Ancillary Study.

Authors:  Rachel P Ogilvie; Michael V Genuardi; Jared W Magnani; Susan Redline; Martha L Daviglus; Neomi Shah; Mayank Kansal; Jianwen Cai; Alberto R Ramos; Barry E Hurwitz; Sonia Ponce; Sanjay R Patel; Carlos J Rodriguez
Journal:  Circ Cardiovasc Imaging       Date:  2020-05-15       Impact factor: 7.792

2.  In-hospital Outcomes and Arrhythmia Burden in Patients with Obstructive Sleep Apnea and Heart Failure with Preserved Ejection Fraction.

Authors:  Jashan Gill; Chunyi Wu
Journal:  J Innov Card Rhythm Manag       Date:  2022-06-15

3.  Predicting Risk of Perioperative Ischemic Optic Neuropathy in Spine Fusion Surgery: A Cohort Study Using the National Inpatient Sample.

Authors:  Shikhar H Shah; Yi-Fan Chen; Heather E Moss; Daniel S Rubin; Charlotte E Joslin; Steven Roth
Journal:  Anesth Analg       Date:  2020-04       Impact factor: 5.108

Review 4.  Is obstructive sleep apnea associated with ventricular tachycardia? A retrospective study from the National Inpatient Sample and a literature review on the pathogenesis of Obstructive Sleep Apnea.

Authors:  Amr Salama; Abdullah Abdullah; Abdul Wahab; George Eigbire; Ryan Hoefen; Ruth Kouides; Nathan Ritter; Hanna Mieszczanska; Richard Alweis
Journal:  Clin Cardiol       Date:  2018-11-24       Impact factor: 2.882

5.  Relationship of Atrial Fibrillation to Outcomes in Patients Hospitalized for Chronic Obstructive Pulmonary Disease Exacerbation.

Authors:  Abdullah Sayied Abdullah; George Eigbire; Mohamed Ali; Mohanad Awadalla; Abdul Wahab; Hisham Ibrahim; Amr Salama; Richard Alweis
Journal:  J Atr Fibrillation       Date:  2019-08-31

6.  Outcome assessment using estimation of left ventricular filling pressure in asymptomatic patients at risk for heart failure with preserved ejection fraction.

Authors:  Anna Bobenko; André Duvinage; Meinhard Mende; Volker Holzendorf; Kathleen Nolte; Christoph Herrmann-Lingen; Lutz Binder; Hans-Dirk Düngen; Gerd Hasenfuss; Burkert Pieske; Rolf Wachter; Frank Edelmann
Journal:  Int J Cardiol Heart Vasc       Date:  2020-05-07

Review 7.  Heart Failure with Preserved Ejection Fraction and Obstructive Sleep Apnea: A Novel Paradigm for Additional Cardiovascular Benefit of SGLT2 Inhibitors in Subjects With or Without Type 2 Diabetes.

Authors:  Vincenzo Maria Monda; Sandro Gentile; Francesca Porcellati; Ersilia Satta; Alessandro Fucili; Marcello Monesi; Felice Strollo
Journal:  Adv Ther       Date:  2022-09-16       Impact factor: 4.070

Review 8.  Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction.

Authors:  Domenico D'Amario; Stefano Migliaro; Josip A Borovac; Attilio Restivo; Rocco Vergallo; Mattia Galli; Antonio Maria Leone; Rocco A Montone; Giampaolo Niccoli; Nadia Aspromonte; Filippo Crea
Journal:  Front Physiol       Date:  2019-11-05       Impact factor: 4.566

9.  Respiratory support in acute heart failure with preserved vs reduced ejection fraction.

Authors:  Thomas S Metkus; Robert Scott Stephens; Steven Schulman; Steven Hsu; David A Morrow; Shaker M Eid
Journal:  Clin Cardiol       Date:  2019-12-11       Impact factor: 2.882

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.